The relationship between cardiac radiation dose and mediastinal lymph node involvement in stage III non-small cell lung cancer patients
Purpose: The results from Radiation Therapy Oncology Group (RTOG) 0617, a dose escalation trial that compared treatment with 60 Gy versus 74 Gy for patients with stage III non-small cell lung cancer (NSCLC), suggested that in these patients, the heart dose from radiation therapy correlates with surv...
Main Authors: | Laura K. McNew, MD, Stephen R. Bowen, PhD, Olga Gopan, PhD, Matthew J. Nyflot, PhD, Shilpen A. Patel, MD, Jing Zeng, MD, Ramesh Rengan, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-04-01
|
Series: | Advances in Radiation Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452109417300131 |
Similar Items
-
How Much Was the Elective Lymph Node Region Covered in Involved-Field Radiation Therapy for Locally Advanced Pancreatic Cancer? Evaluation of Overlap Between Gross Target Volume and Celiac Artery–Superior Mesenteric Artery Lymph Node Regions
by: Rei Umezawa, MD, PhD, et al.
Published: (2020-05-01) -
Schwannoma arising in a lymph node mimicking metastatic pulmonary carcinoma
by: Mitsuhiro Kamiyoshihara, MD., PhD., et al.
Published: (2018-01-01) -
Long-term Results of Microvascular Lymph Node Transfer: Correlation of Preoperative Factors and Operation Outcome
by: Eeva H. Rannikko, MD, et al.
Published: (2021-01-01) -
Anterior Mediastinal Amyloidosis Mimics Thymic Carcinoma
by: Satoshi Ikeda, MD, PhD, et al.
Published: (2020-09-01) -
Abstract: Prefabricated Lympho-Venous Shunt Increases the Efficacy of Lymph Node Transfer for Lymphedema
by: Shinsuke Akita, MD, PhD, et al.
Published: (2017-09-01)